ArticleFrontiers in pharmacology2022

Oleoylethanolamide as a New Therapeutic Strategy to Alleviate Doxorubicin-Induced Cardiotoxicity.

Yeyu Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.